Safe EMLA dosages in neonates, infants and children
Maximum recommended EMLA dosage in neonates, infants and children (intact skin).
| Age group | Max dose(g) | Max skin area(cm2) |
| 0-2 months | 1 | 10 |
| 3-11 months | 2 | 20 |
| 1-5 years | 10 | 100 |
| 6-11 years | 20 | 200 |
Footnote to table: In neonates and infants below 3 months of age the application time should not exceed 1 hour. EMLA should not be used in infants between 0-12 months of age receiving treatment with methaemoglobin-inducing agents (e.g. sulfonamides). In children with atopic dermatitis an application time of 30 min is recommended.
Page tools
Contact
Information for
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below:
